Ecovyst Inc. ECVT

Healthcare SIC 2800 - Chemicals & Allied Products NAICS Manufacturing › Chemical Manufacturing derived NYSE

Ecovyst Inc. ("Ecovyst" or the "Company"), formerly PQ Group Holdings Inc., was incorporated in Delaware on August 7, 2015. We trace our roots to the late 1800s with our first sulfuric acid plant and the beginning of our oldest customer relationship.

Our common stock is listed on the New York Stock Exchange under the stock ticker "ECVT". Unless the context otherwise indicates, the terms "Ecovyst Inc.," "we," "us," "our," or the "Company" mean Ecovyst Inc. and our subsidiaries.

Effective on December 31, 2025, we completed the sale of our Advanced Materials & Catalysts segment, which includes our investment in affiliated companies, Zeolyst International and Zeolyst C.V. (collectively, the "Zeolyst Joint Venture") to Technip Energies N.V. for a purchase price of $556.0 million, subject to certain adjustments set forth in the agreement. We used $465.0 million of the net cash proceeds to partially repay the Senior Secured Term Loan Facility due June 2031. The results of operations, financial condition and cash flows for the Advanced Materials & Catalysts business are presented herein as discontinued operations. Refer to Note 4 to our consolidated financial statements for additional information.

Last close 9.79 2026-10-23
Market cap $1.07B 2026-06-30 share count
52-week range 7.41 - 15.09

Valuation FY2025 figures against the last close

P/S1.5x
P/E—
P/FCF15.3x
EV/EBITDA9.5x
Dividend yield—
Diluted EPS-0.61

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $723.5M$598.3M$584.8M$820.2M$611.2M$495.9M$532.7M$527.7M$1.47B$1.06B
Cost of revenue $565.4M$434.9M$418.4M$595.5M$434.5M$345.0M$365.5M$369.6M$1.10B$810.1M
Gross profit $158.1M$163.4M$166.4M$224.6M$176.7M$151.0M$167.2M$158.0M$376.8M$254.1M
R&D —$6.8M$7.8M$7.2M$7.5M$7.1M$7.4M$8.9M$13.9M$7.3M
SG&A $66.0M$65.4M$60.5M$85.3M$97.8M$81.5M$83.5M$85.0M$146.7M$110.3M
Operating income $64.9M$85.1M$89.6M$104.4M$54.6M$51.6M$66.0M$69.8M$165.9M$81.5M
Interest expense $34.2M$36.5M$31.7M$37.2M$37.0M$50.4M$66.9M$72.3M$179.0M$140.3M
Pre-tax income $25.8M$45.2M$56.9M$94.7M$13.9M$2.2M$43.4M$13.2M-$60.6M-$69.1M
Income tax $19.5M$299.0K$8.7M$24.9M$12.1M$52.1M$12.3M$8.0M$119.2M$10.0M
Net income -$71.1M-$6.7M$71.2M$69.8M$1.8M-$278.8M$79.5M$58.3M$57.6M-$79.7M
EPS, basic -0.62-0.060.600.55-1.03-2.060.590.440.52-1.02
EPS, diluted -0.61-0.060.600.55-1.02-2.040.590.430.52-1.02
Shares, diluted (wtd. avg.) 116.0M117.4M119.5M135.1M137.7M136.5M135.5M134.7M111.7M78.0M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $197.2M$131.4M$72.7M$110.9M$140.9M$113.4M$36.1M$37.2M$66.2M$85.1M
Receivables $85.3M$53.2M$81.3M$74.8M$80.8M$45.9M$140.0M$196.8M$193.5M$160.6M
Inventory $26.8M$18.0M$45.1M$44.4M$53.8M$52.8M$137.6M$264.7M$262.4M$227.0M
Total current assets $319.4M$303.7M$246.0M$267.7M$291.7M$428.7M$569.5M$558.6M$549.0M$492.7M
Property, plant and equipment $481.2M$458.7M$576.9M$584.9M$596.2M$591.7M$1.01B$1.21B$1.23B$1.18B
Goodwill $326.7M$326.6M$404.5M$403.2M$406.1M$391.6M$390.5M$969.7M$1.31B$1.24B
Other intangibles $59.3M$67.7M$116.5M$129.9M$145.6M$137.4M$555.3M$728.4M$786.1M$816.6M
Total assets $1.26B$1.80B$1.84B$1.88B$1.93B$3.20B$4.32B$4.33B$4.42B$4.26B
Accounts payable $48.0M$32.9M$40.2M$40.0M$51.9M$38.1M$115.0M$148.4M$149.3M$128.5M
Short-term debt $0$8.7M$9.0M$9.0M$9.0M$0$0$7.2M$45.2M$14.5M
Total current liabilities $120.8M$115.1M$119.1M$129.4M$145.1M$201.9M$270.4M$255.6M$288.4M$242.4M
Long-term debt $392.6M$852.1M$858.9M$865.9M$872.8M$1.40B$1.84B$2.11B$2.19B$2.55B
Total liabilities $657.5M$1.10B$1.13B$1.18B$1.19B$1.92B$2.54B$2.66B$2.78B$3.23B
Retained earnings -$248.6M-$177.5M-$170.9M-$242.0M-$315.7M-$175.8M$103.0M$25.5M-$32.8M-$90.4M
Total equity $603.4M$700.5M$705.5M$707.2M$740.7M$1.28B$1.79B$1.66B$1.63B$1.03B

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $140.3M$149.9M$137.6M$186.6M$129.9M$223.6M$267.8M$248.6M$165.2M$122.7M
Depreciation and amortisation $67.8M$59.9M$55.3M$79.2M$79.7M$76.9M$74.8M$72.2M$177.1M$128.3M
Stock-based compensation $9.7M$11.1M$13.0M$20.6M$31.8M$17.2M$13.3M$16.9M$8.8M$5.4M
Capital expenditure $70.4M$55.6M$59.0M$58.9M$60.0M$54.8M$55.3M$55.1M$140.5M$121.4M
Investing cash flow $435.4M-$73.5M-$65.3M-$63.0M$835.7M$551.5M-$35.4M-$119.3M-$196.0M-$1.92B
Financing cash flow -$525.0M-$17.8M-$93.5M-$148.2M-$964.2M-$722.8M-$216.1M-$137.2M$19.8M$1.86B
Dividends paid ——$0$0$435.6M$243.7M$0$0——
Buybacks $46.9M$5.0M$78.7M$136.7M$0$2.1M$3.6M$2.9M—$2.5M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001140361-26-014838.

Plot the figures US dollars

  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -500M 0 500M 1B 1.5B Revenue, FY2016: 1.1B Gross profit, FY2016: 254.1M Net income, FY2016: -79.7M Revenue, FY2017: 1.5B Gross profit, FY2017: 376.8M Net income, FY2017: 57.6M Revenue, FY2018: 527.7M Gross profit, FY2018: 158M Net income, FY2018: 58.3M Revenue, FY2019: 532.7M Gross profit, FY2019: 167.2M Net income, FY2019: 79.5M Revenue, FY2020: 495.9M Gross profit, FY2020: 151M Net income, FY2020: -278.8M Revenue, FY2021: 611.2M Gross profit, FY2021: 176.7M Net income, FY2021: 1.8M Revenue, FY2022: 820.2M Gross profit, FY2022: 224.6M Net income, FY2022: 69.8M Revenue, FY2023: 584.8M Gross profit, FY2023: 166.4M Net income, FY2023: 71.2M Revenue, FY2024: 598.3M Gross profit, FY2024: 163.4M Net income, FY2024: -6.7M Revenue, FY2025: 723.5M Gross profit, FY2025: 158.1M Net income, FY2025: -71.1M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $1.06B $1.47B $527.7M $532.7M $495.9M $611.2M $820.2M $584.8M $598.3M $723.5M
Gross profit $254.1M $376.8M $158.0M $167.2M $151.0M $176.7M $224.6M $166.4M $163.4M $158.1M
Net income -$79.7M $57.6M $58.3M $79.5M -$278.8M $1.8M $69.8M $71.2M -$6.7M -$71.1M

Recent filings and events

  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
  • New debt or obligation The company has taken on debt or a comparable obligation. Item 2.03
  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Results announced Item 2.02
  • Material agreement signed Item 1.01
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Results announced Item 2.02
  • Acquisition or disposal completed A purchase or sale of a significant business or asset has closed. Item 2.01

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 2800

TickerCompanyMarket capP/ERevenue growth
SOLS Solstice Advanced Materials Inc. $9.44B 39.9x 3.1%
BCPC BALCHEM CORP $5.64B 37.3x 8.8%
PRM Perimeter Solutions, Inc. $4.55B — 16.4%
IOSP INNOSPEC INC. $2.43B 21.1x -3.7%
NGVT Ingevity Corp $2.39B — -2.7%
CC Chemours Co $1.93B — 0.4%
OLN OLIN Corp $1.78B — 3.7%
HUN Huntsman CORP $1.54B — -5.8%